Cultivecs is a joint venture between Mitsubishi Gas Chemical and Nippon Kayaku formed for contract manufacturing of antibody drugs and other biopharmaceuticals. The company has built a manufacturing facility for antibody drugs at the Mitsubishi Gas Chemicals factory in Niigata which will be delivered in February, 2018, for cultivating CHO cells. According to information by Nikkei Biotech, the facility will use 1000-L single-use culture vessel bioreactors.

Nikkei Biotech news release, January 31, 2018